Principal Secretary for Medical Services Dr Ouma Oluga on Tuesday, August 11, 2026, held talks with Pfizer Biopharmaceuticals Group Vice President for Access and Accord in Emerging Markets, Ali Besri.
The meeting was meant to review the implementation of the Ministry of Health–Pfizer Overseas LLC Memorandum of Understanding.
The agreement, in effect since April 2025 and renewed in May 2026, supports not-for-profit access to Pfizer medicines and vaccines, supply-chain strengthening, regulatory collaboration and health workforce development.
Speaking during the meeting, Dr Oluga called for the partnership to evolve beyond access to medicines into a broader strategic collaboration supporting clinical trials and research, technology transfer, local manufacturing and the establishment of Kenya as a logistics and distribution hub for East Africa.
The meeting also underscored the need to operationalise the Joint Coordination Committee provided for under the agreement.
Additionally, the Committee will oversee implementation, monitor progress and coordinate engagement among the Ministry, Pfizer, the Pharmacy and Poisons Board, Kenya Medical Supplies Authority and other relevant Government agencies.
The proposed collaboration aligns with Kenya’s Health Products and Technologies Local Manufacturing Strategy 2026–2030 and the country’s ambition to strengthen pharmaceutical manufacturing, research, regulation and regional distribution while expanding affordable access to essential and innovative health products.
